[(S)-Alpha-phenyl-2-pyridine-ethanamine dihydrochloride], a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1412-1424

  Cregan, Edward F ^a   Peeling, James ^b   Corbett, Dale ^c   Buchan, Alastair M ^e   Saunders, John ^d   Auer, Roland N ^e   Gao, M ^e   Mccarthy, Dennis J ^a   Eisman, Mark S ^a   Campbell, T Mark ^b   Murray, Robert J ^a   Stagnitto, Mary L ^a   Palmer, Gene C ^a  

^a Astra Arcus USA   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LANICEMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOXIA; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; HYPOXIA; ISCHEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL TIME;

ANIMALS; BRAIN ISCHEMIA; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GERBILLINAE; HIPPOCAMPUS; HYPOXIA, BRAIN; MALE; MICE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PYRIDINES; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 15644379077     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. ALLEGRINI, P. R. AND SAUER, D.: Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis. Mag. Res. Imaging 10: 773-778, 1992.
2. AUER, R. N., ROD, M. R. AND WHISHAW, I. Q.: MK-801 (Dizocilpine) efficacy and limitations in cerebral ischemia. In Excitatory Amino Acids, ed. by B. S. Meldrum, F. Moroni, R. P. Simon and J. H. Woods, pp. 703-709, Raven Press, New York, 1991.
3. BEDERSON, J., PITTS, L. H., TSAJI, M., NISHIMURA, M. C., DAVIS, R. L. AND BARTKOWSKI, H.: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17: 472-476, 1986.
4. BELAYEV, L., BUSTO, R., ZHAO, W. AND GINSBERG, M. D.: HU-211, a novel non-competitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 26: 2313-2320, 1995.
5. BIEGON, A. AND JOSEPH, A. B.: Development of HU-211 as a neuroprotectant for ischemic brain damage. Neurol. Res. 17: 275-280, 1995.
6. BLACK, M. A., TREMBLAY, R., MEALING, G., RAY, R., DURKIN, J. P., WHITFIELD, J. F., BLOSSER, J. AND MORELY, P.: N-methyl-D-aspartate- or glutamate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR. J. Neurochem. 65: 2170-2177, 1995.
7. BMDP STATISTICAL SOFTWARE, University of California Press, Berkley, CA, 1981.
8. BUCHAN, A. M.: Do NMDA antagonists protect against cerebral ischemia: Are clinical trials warranted? Cerebrovasc. Brain Metab. Rev. 2: 1-26, 1990.
9. BUCHAN, A. M., XUE, D. AND SIVKA, A.: A new model of temporary focal neocortical ischemia in the rat. Stroke 23: 273-279, 1992.
10. BUSTO, R., DIETRICH, W. D., GLOBUS, M. Y.-T., VALDES, I., SCHEINBERG, P. AND GINSBERG, M. D.: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7: 729-738, 1987.
11. CHAPMAN, A. G., SWAN, J. H., PATEL, S., GRAHAM, J. L. AND MELDRUM, B. S.: Cerebroprotective and anticonvulsant action of competitive and non-competitive NMDA antagonists. In Amino Acids: Chemistry, Biology and Medicine, ed. by G. Lubec and G. A. Rosenthal, pp. 219-232, ESCOM Science Publishers, Amsterdam, 1990.
12. COLLINS, R. C., DOBKIN, B. H. AND CHOI D. W.: Selective vulnerability of the brain: New insights into the pathophysiology of stroke. Ann. Intern. Med. 110: 992-1000, 1989.
13. CORBETT, D., EVANS, S., THOMAS, C., WANG, D. AND JONAS, R. A.: MK-801 reduces cerebral ischemic injury by inducing hypothermia. Brain Res. 514: 300-304, 1990.
14. CREGAN, E. F., HOWELL, A. S., STAGNITTO, M. L., MURRAY, R. J., MILLER, J. A. AND PALMER, G. C.: Protection of rodents against global ischemia by FPL 15896AR. Soc. Neurosci. 21: 995, 1995.
15. FEENEY, D. M., BOYESON, M. G., LINN, R. T., MURRAY, H. M. AND DAIL, W. G.: Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 211: 67-77, 1981.
16. GEE, K. R.: Therapeutic potential of PCP receptor ligands. Exp. Opin. Invest. Drugs 3: 1020-1030, 1994.
17. GINSBERG, M. D. AND BUSTO, R.: Rodent models of cerebral ischemia. Stroke 20: 1627-1642, 1989.
18. GRABOWSKI, M., BRUNDIN, P. AND JOHANSSON, B. B.: Paw-reaching, sensorimotor and rotational behavior after brain infarction in rats. Stroke 24: 889-895, 1993.
19. GREENE, J. G., PORTER, R. H. AND GREENAMYRE, J. T.: ARL-15896, a novel N-methyl-D-aspartate receptor ion channel antagonist: Neuroprotection against mitochondrial metabolic toxicity and regional pharmacology. Exp. Neural. 137: 66-72, 1996.
20. HARRIS, E. W.: Subtypes of glutamate receptors: Pharmacological classification. In CNS Neurotransmitters and Modulators Glutamate, ed. by T. W. Stone, pp. 95-125, CRC Press, New York, 1995.
21. HERZ, R. C. G., JONKER, M., VERHEUL, H. B., HILLEN, B., VERSTEEG, D. H. G. AND DE WILDT, D. J.: Middle cerebral artery occlusion in Wistar and Fischer-344 rats: Functional and morphological assessment of the model. J. Cereb. Blood Flow Metab. 16: 296-302, 1996.
22. HEWITT, K. AND CORBETT, D.: Combined treatment with MK-801 and nicardipine reduces global ischemic damage in the gerbil. Stroke 23: 82-86, 1992.
23. HUDZIK, T. J. AND PALMER, G. C.: Effects of anticonvulsants in a novel operant learning paradigm in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents. Epilepsy Res. 21: 183-193, 1995.
24. HUDZIK, T. J., FREEDMAN, L. AND PALMER, G. C.: Remacemide hydrochloride and ARL 15896AR lack abuse potential: Additional differences from other uncompetitive NMDA antagonists. Epilepsia 37: 544-550, 1996.
25. JENSEN, M. L. AND AUER, R. N.: Intraventricular infusion of the selective 5-agonist 1,3-di-ortho-tolylguanidine (DTG) mitigates ischaemic brain damage in the hippocampus. Neurol. Res. 13: 257-260, 1991.
26. KNIGHT, R. A., DERESKI, M. O., HEPERN, J. A., ORDIDGE, R. J. AND CHOPP, M.: Magnetic resonance imaging assessment of evolving focal cerebral ischemia: Comparison with histopathology in rats. Stroke 25: 1252-1262, 1994.
27. KNOWLES, M. A., CRAMER, C. L., STAGNITTO, M. L., FREEDMAN, L. R., WATKINS, B. E., MURRAY, R. J., BALESTRA, M. AND PALMER, G. C.: Anti-epileptic potential of FPL 15896AR. FASEB J. 9: A394, 1995.
28. MAHMOOD, N. A., CASE, K. R., EISMAN, M. S., MCCARTHY, D. J., OSTERHOUT, J. L. AND WHITE, J.: Stereoselective brain uptake in male rats of FPL 15896AR, a novel neuroprotective agent. New Strategies to Prevent Neural Damage from Ischemic Stroke. Cambridge Healthtech Inst. Symp., poster no. 4, 1994.
29. MCCULLOCH, J.: Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br. J. Clin. Pharmacol. 34: 106-114, 1992.
30. MELDRUM, B.: Excitatory amino acids and neuroprotection. In Advances in Neuroprotection Emerging Strategies in Neuroprotection, ed. by P. J. Marangos and H. Lal, pp. 106-128, Birkhauser, Boston, MA, 1992.
31. MILDE, L. N.: The hypoxic mouse model for screening cerebral protective agents: A re-examination. Anesth. Analg. 67: 917-922, 1988.
32. MINEMATSU, K., FISHER, M., LI, L., DAVIS, M. A., KNAPP, A. G., COTTER, R. E., MCBURNEY, R. N. AND SOTAK, C. H.: Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology 43: 397-403, 1993.
33. MONTOYA, C. P., CAMPBELL-HOPE, L. J., PEMBERTON, K. D. AND DUNNETT, S. B.: The staircase test: A measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36: 219-228, 1991.
34. OLNEY, J. W.: Neurotoxicity of excitatory amino acids. In Kainic Acid as a Tool in Neurobiology, ed. by E. G. McGeer, J. W. Olney and P. L. McGeer, pp. 37-70, Raven Press, New York, 1978.
35. ORDY, J. M., VOLPE, B., MURRAY, R., THOMAS, G., BIALOBOK, P., WENGENACK, T. M. AND DUNLAP, W.: Pharmacological effects of remacemide and MK-801 on memory and hippocampal CAl damage in the rat four-vessel occlusion (4-VO) model of global ischemia. In The Role of Neurotransmitters in Brain Injury, ed. by M. Globus and W. D. Dietrich, pp. 83-92, Plenum Press, New York, 1992.
36. PALMER, G. C., CREGAN, E. F., BORRELLI, A. R. AND WILLETT, F.: Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride. Ann. N.Y. Acad. Sci. 765: 236-247, 1995a.
37. PALMER, G. C., CREGAN, E. F., BORRELLI, A. R., HARRIS, E. W., STAGNITTO, M. L., COLOMBO, P., KAISER, F. C., MURRAY, R. J., GRIFFITH, R. C. AND STRAND, J. C.: Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia. J. Pharmacol. Exp. Ther. 274: 991-1000, 1995b.
38. PALMER, G. C., MURRAY, R. J. AND MCCARTHY, D. J.: Neuroprotective potential of the low affinity NMDA receptor antagonist, ARL 15896AR. In Ischemic Stroke II - Advances in the Understanding and Therapy, ed. by L. M. Savage, pp. 34-64, IBC Biomed. Library Series, Suthborough, MA, 1996.
39. PAXINOS, G. AND WATSON, C.: The Rat Brain In Stereotaxic Coordinates, pp. 1-13, Academic Press, New York, 1982.
40. POIGNET, H., NOWICKI, J. P. AND SCATTON, B.: Lack of neuroprotective effect of some & ligands in a model of focal cerebral ischemia in the mouse. Brain Res. 596: 320-324, 1992.
41. PULSINELLI, W. A. AND BRIERLY, J.: A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10: 267-272, 1979.
42. PULSINELLI, W. A. AND BUCHAN, A. M.: The four-vessel occlusion rat model: Method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke 44: 279-292, 1992.
43. PULSINELLI, W. A. AND BUCHAN, A.: The NMDA receptor/ion channel: Its importance to in vivo ischemic injury to selectively vulnerable neurons. In Pharmacology of Cerebral Ischemia, ed. by J. Krieglstein and H. Oberpichler, pp. 169-175, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1990.
44. ROGAWSKI, M. A., YAMAGUCHI, S-I., JONES, S. M., RICE, K. C., THURKAUF, A. AND MONIN, J. A.: Anticonvulsant activity of the low affinity uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5,10-imine (ADCI): Comparison with the structural analogs dizocilpine (MK-801) and carbamazepine. J. Pharmacol. Exp. Ther. 259: 30-37, 1991.
45. ROGAWSKI, M. A.: The NMDA receptor, NMDA antagonists and epilepsy therapy: A status report. Drugs 44: 279-292, 1992.
46. RUDIN, M. AND SAUER, D.: In vivo NMR in pharmaceutical research. Magnet. Reson. Imaging 10: 721-731, 1992.
47. SHUAIB, A., IJAZ, S., MAZAGRI, R. AND SENTHILSEVLVAN, A.: CGS-19755 is neuroprotective during repetitive ischemia: This effect is significantly enhanced when combined with hypothermia. Neuroscience 56: 915-920, 1993.
48. SMITH, M-L., BENDEK, G., DAIILGREN, N., ROSEN, I., WIELOCH, T. AND SIESJO, B. K.: Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol. Scand. 69: 385-401, 1984.
49. STEER, C. R.: Barbiturate therapy in the management of cerebral ischaemia. Dev. Med. Child. Neurol. 24: 219-231, 1982.
50. STEINBERG, G. K., KUNIS, D., SALEH, J. AND DE LAPAZ, R.: Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. J. Cereb. Blood Flow Metab. 11: 1015-1024, 1991.
51. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations and Computer Programs, 2nd ed., chap. 36, pp. 121-125, Springer, New York, 1987.
52. UNGERSTEDT, U. AND ARBUTHNOTT, G. W.: Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigro-striatal dopamine system. Brain Res. 24: 485-493, 1970.
53. 2 and diffusion-weighted magnetic resonance imaging of a focal ischemic lesion in rat brain. Stroke 23: 576-582, 1992.
54. ZHU, C. Z. AND AUER, R. N.: Graded hypotension and MCA occlusion duration: Effect in transient focal ischemia. J. Cereb. Blood Flow Metab. 15: 980-988, 1995.